Dergiler / Gülhane Tıp Dergisi / 2021 / Cilt: 63 - Sayı: 1

Evaluation of risk factors and causative pathogens in bloodstream infections in cancer patients

Sayfa
42–51
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Therefore, it is recommended to start with broad-spectrum antibiotics in bloodstream infections.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aims: Bloodstream infection in cancer patients may cause delays in chemotherapy, prolonged hospital stay, difficulties in diagnosis and treatment, inappropriate treatment, high mortality rates and increased health care costs.
📊
Temel Bulgular & Veri:The study included patients who were followed up and treated with the diagnosis of hematologic malignancy or solid tumor and who were found to have bloodstream infection during the period from 01/01/2014 to 12/31/2018 and patients with similar characteristics as the control group.
💡
Sonuç & Katkı:Therefore, it is recommended to start with broad-spectrum antibiotics in bloodstream infections.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Aims: Bloodstream infection in cancer patients may cause delays in chemotherapy, prolonged hospital stay, difficulties in diagnosis and treatment, inappropriate treatment, high mortality rates and increased health care costs. The aim of this study was to evaluate the risk factors and causative pathogens in bloodstream infection in cancer patients. Methods: The study was planned as a retrospective case-control study. The study included patients who were followed up and treated with the diagnosis of hematologic malignancy or solid tumor and who were found to have bloodstream infection during the period from 01/01/2014 to 12/31/2018 and patients with similar characteristics as the control group. Results: A total of 312 (276 hematologic malignancy, 36 solid tumor) bloodstream infections were included. The presence of central venous catheter (CVC), steroid use, presence of urinary catheter, neutrophil count, neutropenia duration and total hospitalization day were determined as independent risk factors of bloodstream infection in patients with hematologic malignancy. The presence of CVC, total parenteral nutrition, renal failure and neutrophil count were determined as independent risk factors of bloodstream infection in patients with solid tumor. In patients with hematologic malignancy, 113 Escherichia coli and 59 Klebsiella pneumoniae were detected. In patients with solid tumor, 7 E. coli and 5 K. pneumoniae were detected. Conclusions: Risk factors are higher in the development of bloodstream infection in patients with hematologic malignancy and patients should be closely monitored. Multidrug-resistant bacteria might also be isolated from the blood cultures of patients. Therefore, it is recommended to start with broad-spectrum antibiotics in bloodstream infections.

🔖

Bu Makaleye Atıf Yap

ERTEK, M., ÇAKAR, M. K., MERDİN, A., MERT, D., ÇEKEN, S., ALTUNTAŞ, F., KANDEMİR, N., DİRİM, E. (2022). Evaluation of risk factors and causative pathogens in bloodstream infections in cancer patients. Gülhane Tıp Dergisi, Cilt: 63 - Sayı: 1, 42–51. https://ajindex.com/articles/526799

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760-766
  2. Marín M, Gudiol C, Ardanuy C, et al. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. J Infect. 2014;69:417-423
  3. Montassier E, Batard E, Gastinne T, Potel G, de La Cochetière MF. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841-850
  4. Fridkin SK. The changing face of fungal infections in health care settings. Clin Infect Dis. 2005;41:1455-1460
  5. Safdar A, Armstrong D. Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis. 2011;53:798-806
  6. Hübel K, Hegener K, Schnell R, et al. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol. 1999;78:73-77
  7. Obeng-Nkrumah N, Labi AK, Acquah ME, Donkor ES. Bloodstream infections in patients with malignancies: implications for antibiotic treatment in a Ghanaian tertiary setting. BMC Res Notes. 2015;8:742
  8. Graff LR, Franklin KK, Witt L, et al. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. Am J Med. 2002;112:204-211
  9. Vidal F, Mensa J, Almela M, et al. Bacteraemia in adults due to glucose non-fermentative Gram-negative bacilli other than P. aeruginosa. QJM. 2003;96:227-234
  10. Shmuely H, Pitlik S, Yahav J, Samra Z, Leibovici L. Sevenyear study of bacteremia in hospitalized patients on chronic hemodialysis in a single tertiary hospital. Ren Fail. 2003;25:579-588
  11. Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP; CDC Prevention Epicenters Program. Both host and pathogen factors predispose to Escherichia coli urinarysource bacteremia in hospitalized patients. Clin Infect Dis. 2012;54:1692-1698
  12. Safdar A, Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin. 2001;17:531-570
  13. Velasco E, Soares M, Byington R, et al. Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in adult surgical cancer patients. Eur J Cli